Second Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310005, China
Location status: Recruiting
Location contact
Yi Dong
CONTACT
Recruiting
NCT Number: NCT04965558
Clinical Features and Outcome in Patients With Osseomuscular Type of Wilson's Disease
The investigators aimed to observe the clinical features and outcome in patients with osseomuscular type of Wilson's disease from a large cohort during long-term follow-up
Recruiting
Interested in participating?
Request InfoKey information
Conditions
Age range
6 year–65 year
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- genetically diagnosed WD patients
Exclusion criteria
- Deny follow-up
Treatment and study plan
No intervention
OtherNo intervention
Primary outcomes
-
Serum ceruloplasmin
Time frame: From 2004 through 2030
Serum ceruloplasmin levels were collected among patients with wilson disease. After confirming a non-Gaussian distribution, the reference range of serum ceruloplasmin level was determined.
-
Urinary Copper Excretion
Time frame: From 2004 through 2030
The measurement of 24-hour urine copper excretions were collected and measured.
Study contacts
Contact information is provided by the study sponsor or research team.
Sponsors and collaborators
Lead sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Other
Registry information
Important dates
- Study start
- 2004
- Primary completion
- 2025
- Study completion
- 2030
- First posted
- Jul 16, 2021
- Registry last updated
- Jul 16, 2021
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.